Gili Amid-Toby1*, Emily Garelick2, Shaina Gagadam2, Yazmin William3, Katheryn Bell4, Kelly Fraiser5
1Dr Phillip Frost, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of
Miami, Miami, FL, USA
2Philadelphia College of Osteopathic Medicine, PA, USA
3Rowan-Virtua School of Osteopathic Medicine, NJ, USA
4Indiana University School of Medicine, IN, USA
5Department of Dermatology, Northwell Health, New Hyde Park, NY, USA
*Corresponding author: Gili Amid-Toby, BS, Miller School of Medicine, University of Miami, Miami, FL, USA, 1150 NW 14th St, Miami, FL 33136, E-mail:[email protected]
Received Date: September 15, 2025
Publication Date: February 04, 2026
Citation: Toby G, et al. (2025). Challenges and Opportunities in Infantile Hemangioma Care Through Telemedicine. Dermis. 6(1):57.
Copyright: Amid-Toby G, et al. © (2026).
ABSTRACT
Infantile hemangiomas (IHs) are the most common vascular tumors of infancy. While many regress spontaneously, a subset cause functional impairment, ulceration, or permanent cosmetic sequelae, making early recognition and timely treatment critical to prevent morbidity. With the growth of digital health, telemedicine has become increasingly relevant for IH evaluation and management. This narrative review examines the role of telemedicine in IH care, focusing on its benefits, limitations, and potential risks. Literature was identified through targeted searches of PubMed and Google Scholar using the terms infantile hemangioma, telemedicine, tele dermatology, diagnosis, and management, with priority given to clinical guidelines, systematic reviews, and large cohort studies. Telemedicine improves access, reduces wait times, and supports continuity of care. However, challenges include difficulty assessing lesion depth and high-risk features remotely, inconsistent image quality, and patient loss to follow-up. Risks are especially significant for syndromic IHs such as PHACE and LUMBAR, as well as for lesions threatening vision, airway function, or cardiac output. Emerging platforms that incorporate standardized imaging protocols and consistent triage processes show promise for improving diagnostic accuracy and follow-up adherence. Overall, telemedicine plays an important role in IH care, but it works best when paired with in-person evaluations as part of an integrated approach. Future work should aim to establish clear protocols and carry out comparative studies to better define best practices and ensure patient safety and outcomes.
Keywords: Diagnostic Accuracy, Infantile Hemangioma, Risk Stratification, Teledermatology, Telemedicine